Swimmer's ear is usually treated with prescription antibiotics but frequent repeat infections may benefit from a home remedy ...

Glue ear – or, to give it its proper medical name, otitis media with effusion (OME) – is a condition where fluid builds up in ...

Ear infection symptoms usually include a fever, ear pain or fullness, and a headache in children and adults. Antibiotics ...

I've had terrible acne on my back for weeks now. It's uncomfortable against my clothes. What should I do? Dr Ellie Cannon ...

Kedrion Biopharma, a global company that collects human blood plasma to produce and distribute plasma-derived therapies for rare and ultra-rare diseases, announced that it has received US FDA approval ...

As OpenAI tells it, the company has been consistently rolling out safety updates ever since parents, Matthew and Maria Raine, sued OpenAI, alleging that "ChatGPT killed my son." On August 26, the day ...

Hearing loss becomes increasingly more prevalent as we get older. In fact, more than 37.5 million American adults experience hearing loss, according to the National Institute on Deafness and ...

Dr. Paul Klotman, the longtime leader at Baylor College of Medicine, will retire in June after overseeing the university through a 15-year period marked by dramatic growth, a global pandemic and, more ...

Part A results demonstrated efficacy and safety; ATSN-201 on track to be first gene therapy and one-time treatment for XLRS DURHAM, N.C., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a ...

Recommendation for adults and adolescents based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo If approved, Dupixent would be the first ...

You have the Oura ring, the smart blackout masks, and the mattress that cools to the perfect temperature to facilitate REM. You’ve tried sleepy-time teas, the legs-up-the-wall pose, and impeccable ...

The U.S. Food and Drug Administration (FDA) on Thursday approved Incyte Corporation’s (NASDAQ:INCY) announced Opzelura (ruxolitinib) cream 1.5% for the short-term and non-continuous chronic treatment ...